Implementing physics-based digital patient twins to tailor the switch of oral morphine to transdermal fentanyl patches based on patient physiology

被引:3
作者
Bahrami, Flora [1 ,2 ]
Rossi, Rene Michel [1 ]
De Nys, Katelijne [3 ,4 ]
Joerger, Markus [5 ]
Radenkovic, Milena Cukic [1 ]
Defraeye, Thijs [1 ]
机构
[1] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Biomimet Membranes & Text, Lerchenfeldstr 5, CH-9014 St Gallen, Switzerland
[2] Univ Bern, ARTORG Ctr Biomed Engn Res, Mittelstr 43, CH-3012 Bern, Switzerland
[3] Kantonsspital St Gallen, Palliativzentrum, Rorschacherstr 95, CH-9000 St Gallen, Switzerland
[4] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, ON2 Herestr 49 Box 424, BE-3000 Leuven, Belgium
[5] Kantonsspital St Gallen, Med Onkol & Hamatol, Rorschacherstr 95, CH-9000 St Gallen, Switzerland
关键词
Opioid therapy; Pharmacokinetics model; Pharmacodynamics model; Tailored therapy; Virtual population; PHARMACOKINETICS; MANAGEMENT; AGE; FORMULATION; EFFICACY; GENDER; MODELS;
D O I
10.1016/j.ejps.2024.106727
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fentanyl transdermal patches are widely implemented for cancer -induced pain treatment due to the high potency of fentanyl and gradual drug release. However, transdermal fentanyl up -titration for opioid-naive patients is difficult, which is why opioid treatment is often started with oral/iv morphine. Based on the daily dose of morphine, the initial dose of the fentanyl patch is decided upon. After reaching a stable level of pain, the switch is made from oral/iv morphine to transdermal fentanyl. There are standard calculation tools for transferring from oral/iv morphine to transdermal fentanyl, which is the same for all patients. By considering the variations in the physiology of the patients, a unique switching strategy cannot meet the needs of different patients. This study explores the outcome in terms of pain relief and minute ventilation during opioid therapy. For this, we used physics -based simulations on a virtually -generated population of patients, and we applied the same therapy to all patients. We could show that patients' physiology, such as gender, age, and weight, greatly impact the outcome of the therapy; as such, the correlation coefficient between pain intensity and age is 0.89, and the correlation coefficient between patient's weight and maximum plasma concentration of morphine and fentanyl is -0.98 and -0.97. Additionally, a different combination of the duration of overlap between morphine and fentanyl therapy with different doses of fentanyl was considered for the virtual patients to find the best opioid-switching strategy for each patient. We explored the impact of combining physiological features to determine the best -suited strategy for virtual patients. Our findings suggest that tailoring morphine and fentanyl therapy only based on a limited number of features is insufficient, and increasing the number of impactful physiological features positively influences the outcome of the therapy.
引用
收藏
页数:19
相关论文
共 51 条
  • [1] [Anonymous], 2016, Morphine Sulfate Injection
  • [2] An individualized digital twin of a patient for transdermal fentanyl therapy for chronic pain management
    Bahrami, Flora
    Rossi, Rene Michel
    De Nys, Katelijne
    Defraeye, Thijs
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (09) : 2272 - 2285
  • [3] Predicting transdermal fentanyl delivery using physics-based simulations for tailored therapy based on the age
    Bahrami, Flora
    Rossi, Rene Michel
    Defraeye, Thijs
    [J]. DRUG DELIVERY, 2022, 29 (01) : 950 - 969
  • [4] Bisaso K.R., 2022, Inform. Med. Unlocked, V28, P100813
  • [5] Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients
    Björkman, S
    Wada, DR
    Stanski, DR
    [J]. ANESTHESIOLOGY, 1998, 88 (03) : 657 - 667
  • [6] Reduction and lumping of physiologically based pharmacokinetic models:: Prediction of the disposition of fentanyl and pethidine in humans by successively simplified models
    Björkman, S
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2003, 30 (04) : 285 - 307
  • [7] Comparative pharmacokinetics of two modified-release oral morphine formulations (Reliadol® and Kapanol®) and an immediate-release morphine tablet (Morfin 'DAK') in healthy volunteers
    Bochner, F
    Somogyi, AA
    Christrup, LL
    Larsen, U
    Danz, C
    Elbaek, K
    [J]. CLINICAL DRUG INVESTIGATION, 1999, 17 (01) : 59 - 66
  • [8] Age-dependent changes in stratum corneum barrier function
    Boireau-Adamezyk, E.
    Baillet-Guffroy, A.
    Stamatas, G. N.
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2014, 20 (04) : 409 - 415
  • [9] Child CG, 1964, Surgery and portal hypertension. The Liver and Portal Hypertension
  • [10] The Analgesic Efficacy and Safety of a Novel Intranasal Morphine Formulation (Morphine plus Chitosan), Immediate Release Oral Morphine, Intravenous Morphine, and Placebo in a Postsurgical Dental Pain Model
    Christensen, Kyle S.
    Cohen, Amy E.
    Mermelstein, Fred H.
    Hamilton, Douglas A.
    McNicol, Ewan
    Babul, Najib
    Carr, Daniel B.
    [J]. ANESTHESIA AND ANALGESIA, 2008, 107 (06) : 2018 - 2024